Leading Innovation and Developing 21st Century Medicines
Artificial Intelligence
Advancing Biomarker Discovery and Therapeutic Development
SMDG is utilizing its therapeutic and diagnostic platforms, combined by Artificial Intelligence and Machine Learning (AI/ML) to design First-in-Class therapies for most debilitating diseases.
A TOOLBOX to advance research, diagnose disease and develop better therapies
We utilize our pioneering Peptide Therapeutic Platforms combined with AI/ML to address a wide range of complex medical conditions. Our focus spans neurological diseases, rare pediatric disorders, cancer, and inflammatory diseases.
We are driven by a mission to introduce groundbreaking technologies that have the potential to revolutionize healthcare and significantly improve patient outcomes.
How are we different from other companies that use AI?
We use AI as a part of multi-component TOOLBOX to discover, decipher, diagnose, design and develop (5D).
In addition, while most other companies have come to AI from computer science and management background, our team includes world-renowned scientists with extensive experience in many fundamental science and medical subjects including protein engineering, drug delivery, drug design, immunology, inflammation and complement, chemistry, nanomedicine, neuroscience, cancer, pediatric medicine and inflammatory diseases in addition to extensive and broad experience and capability in designing AI/ML platforms.
We are designing and developing Tomorrow's Medicines(TM).
Revolutionizing neurological diseases
SMDG is dedicated to developing cutting-edge therapeutics for a range of medical conditions, with a primary focus on neurological diseases.
Cutting-edge Therapeutics
One of the key focus areas for SMDG are inflammatory diseases, where we are using AI/ML and therapeutic platforms to develop novel treatments. Through beyond the state of the art research and development efforts, we aim to revolutionize the way inflammatory diseases are treated, potentially offering more effective and targeted therapies for patients.
Rare pediatric diseases
We are developing groundbreaking advancements to combat rare pediatric diseases and other medical conditions that have long posed significant challenges .